NDC 24208-299
LOTEMAX
Loteprednol Etabonate
LOTEMAX is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Loteprednol Etabonate.
| Product ID | 24208-299_789b4b29-2a0c-4924-9718-5f4f306d2097 |
| NDC | 24208-299 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LOTEMAX |
| Generic Name | Loteprednol Etabonate |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1998-03-09 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020583 |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LOTEPREDNOL ETABONATE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 24208-299-01
1 BOTTLE in 1 CARTON (24208-299-01) > 1 mL in 1 BOTTLE
| Marketing Start Date | 2020-12-15 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
NDC SPL Data Element Entries
NDC 24208-299-15 [24208029915]
LOTEMAX SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA020583 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1998-09-03 |
NDC 24208-299-10 [24208029910]
LOTEMAX SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA020583 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1998-09-03 |
NDC 24208-299-25 [24208029925]
LOTEMAX SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA020583 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1998-03-09 |
| Marketing End Date | 2013-04-11 |
NDC 24208-299-05 [24208029905]
LOTEMAX SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA020583 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1998-09-03 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LOTEPREDNOL ETABONATE | 5 mg/mL |
OpenFDA Data
| SPL SET ID: | f37d74ac-5f9c-40a8-b43b-35148fc66bbe |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Corticosteroid [EPC]
- Corticosteroid Hormone Receptor Agonists [MoA]
Medicade Reported Pricing
24208029915 LOTEMAX 0.5% EYE DROPS
Pricing Unit: ML | Drug Type:
24208029910 LOTEMAX 0.5% EYE DROPS
Pricing Unit: ML | Drug Type:
24208029905 LOTEMAX 0.5% EYE DROPS
Pricing Unit: ML | Drug Type:
NDC Crossover Matching brand name "LOTEMAX" or generic name "Loteprednol Etabonate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24208-299 | LOTEMAX | loteprednol etabonate |
| 24208-443 | Lotemax | loteprednol etabonate |
| 24208-503 | LOTEMAX | loteprednol etabonate |
| 24208-353 | Alrex | loteprednol etabonate |
| 71571-333 | Eysuvis | loteprednol etabonate |
| 71571-121 | Inveltys | loteprednol etabonate |
| 24208-507 | Lotemax SM | loteprednol etabonate |
| 17478-830 | Loteprednol Etabonate | Loteprednol Etabonate |
| 24208-508 | Loteprednol Etabonate | loteprednol etabonate |
| 50383-265 | Loteprednol Etabonate | Loteprednol Etabonate |
| 62756-232 | Loteprednol Etabonate | Loteprednol Etabonate |
| 68682-299 | Loteprednol Etabonate | loteprednol etabonate |
Trademark Results [LOTEMAX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LOTEMAX 74610747 2182587 Live/Registered |
BAUSCH & LOMB INCORPORATED 1994-12-13 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.